Search, analyze & compare

Company details

Ascendis Pharma A/S is a biopharmaceutical company with a focus on developing innovative therapies for rare endocrine diseases and growth disorders. The company's primary function is the research and development of new products that utilize proprietary TransCon technology, which is designed to improve the therapeutic efficacy and safety of existing treatment options. One of the key sectors impacted by Ascendis Pharma’s work is the healthcare industry, particularly areas concerning hormonal and metabolic disorders. Ascendis Pharma A/S undertakes an essential role in addressing unmet medical needs by advancing a pipeline of potential therapies that include treatments for hypoparathyroidism, growth hormone deficiency, and achondroplasia. Founded in 2006 and based in Denmark, the company has a significant presence in Europe and the United States. Its efforts to deliver efficient therapeutic solutions have marked its importance in the biotechnology field, contributing to the advancement and innovation in medical treatments globally.